The Collaborative AIDS Program of Research in South Africa (CAPRISA) is a multi-institutional team with well established local leadership and expertise in the areas of basic and molecular epidemiology, virology, immunology, infectious disease medicine, HIV primary care and service delivery, bioinformatics, social and behavioral science, statistics, ethics and health policy. CAPRISA has three goals; i) to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis and epidemiology as well as the nexus between tuberculosis and AIDS care, ii) to build local research infrastructure though cores of expertise and iii) to provide training through research fellowships tenable both in South Africa and the USA. CAPRISA comprises four research projects. (1) The epidemiological studies on monitoring and deciphering the nuances of the evolving HIV/AIDS epidemic in a rural South African community lay the foundation for assessing the impact of therapeutic and prevention programs at community level. (2) The clinical, immunological and virological studies on acute HIV infection elucidate the host and viral factors influencing the viral set point and immune escape. Since the set point is currently the best prognostic marker of progression to AIDS, these data could have a substantial impact on future therapeutic and prevention research. (3) Linked to this is the study on highly exposed persistently seronegative individuals, which will provide clues to the genetic and immunological mechanisms of protection from HIV infection. (4) The innovative clinical study integrating antiretroviral therapy into the tuberculosis directly observed therapy strategy could provide a mechanism for facilitating the implementation of antiretroviral therapy, with high levels of adherence, in developing countries. An Executive Committee comprising the Project and Core Leaders governs CAPRISA. Besides managing the day-to-day CAPRISA operations, this committee also develops plans for future studies for review by the CAPRISA Scientific Advisory Board. Local research infrastructure is built through Cores for administration, epidemiology/biostatistics, viral diversity/bioinformatics and immunology. South African laboratories will be equipped to conduct assays locally and international collaborators will assist with training, advice, support, assay development and quality control. The training program includes several long- and short-term fellowships each year in laboratory science, clinical and epidemiological research and ethics. If successful, CAPRISA could make seminal contributions to understanding the epidemiology of the subtype C, heterosexually acquired HIV infection, elaborating early immune responses in HIV infection, developing an understanding of the phenomenon of resistance to HIV infection, and making a contribution to AIDS care relevant to the developing world.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DET-A (J2))
Program Officer
Hoff, Rodney
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Kwazulu-Natal
South Africa
Zip Code
Sheward, Daniel J; Marais, Jinny; Bekker, Valerie et al. (2018) HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth. Cell Host Microbe 24:593-599.e3
Johnson, Erik L; Doria-Rose, Nicole A; Gorman, Jason et al. (2018) Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation. Nat Commun 9:4136
Garrett, Nigel; Norman, Emily; Leask, Kerry et al. (2018) Acceptability of Early Antiretroviral Therapy Among South African Women. AIDS Behav 22:1018-1024
Setliff, Ian; McDonnell, Wyatt J; Raju, Nagarajan et al. (2018) Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection. Cell Host Microbe 23:845-854.e6
Harichund, Charlene; Moshabela, M (2018) Acceptability of HIV Self-Testing in Sub-Saharan Africa: Scoping Study. AIDS Behav 22:560-568
Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Augustine, Stanton (2018) A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection. Infect Dis Poverty 7:35
Moosa, Yumna; Tanko, Ramla F; Ramsuran, Veron et al. (2018) Case report: mechanisms of HIV elite control in two African women. BMC Infect Dis 18:54
Selhorst, Philippe; Masson, Lindi; Ismail, Sherazaan D et al. (2017) Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants. Clin Infect Dis 64:79-82
Scheepers, Cathrine; Chowdhury, Sudipa; Wright, W Shea et al. (2017) Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses. AIDS 31:2199-2209
Ngandu, Nobubelo K; Carlson, Jonathan M; Chopera, Denis R et al. (2017) Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide. J Acquir Immune Defic Syndr 76:43-47

Showing the most recent 10 out of 188 publications